Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesRecommendations for the use of medications with continuous enteral nutrition
American Journal of Health-System Pharmacy, 08/11/09
Wohlt PD et al. – There was a lack of published data regarding drug–nutrient interactions for a majority of the drugs commonly administered to patients receiving continuous enteral nutrition. Clinicians should recognize potential drug–nutrient interactions and use available evidence to optimize patients' drug therapy.
Related Articles
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists
Clinical Therapeutics, 10/15/09
Relevance Score: 72%
Quantitative prediction and clinical observation of a cyp3a inhibitor-based drug-drug interactions with mln3897, a potent ccr1 antagonist
Journal of Pharmacology and Experimental Therapeutics, 11/12/09
Relevance Score: 69%
Prediction of Human Drug and Drug Interactions from Time-Dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-Based Simulator
Drug Metabolism and Disposition, 10/06/09
Relevance Score: 69%
Human Mesenchymal Stem Cells and Immunosuppressive Drug Interactions in Allogeneic Responses: An In Vitro Study Using Human Cells
Transplantation Proceedings, 11/13/09
Relevance Score: 68%
Clinically Significant Adverse Events from a Drug Interaction Between Quetiapine and Atazanavir-Ritonavir in Two Patients
Pharmacotherapy, 10/27/09
Relevance Score: 68%
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor